Illinois Eye and Ear Infirmary

Prevent Blindness Declares August as Children's Eye Health and Safety Month to Help Educate Families on the Importance of Healthy Vision and Early Access to Eyecare

Retrieved on: 
Monday, July 31, 2023
Eye Health UK, Strabismus, University, NEI, Visual impairment, Illinois Eye and Ear Infirmary, Head, Parent, University of Illinois Chicago College of Dentistry, Family, Amblyopia, MBA, Vision, Visual Science, MSC, MD, National Eye Institute, University of Illinois Urbana-Champaign, FACS, Near-sightedness, Caregiver, Retinopathy, Ear, Social media, Management, Ophthalmology

CHICAGO, July 31, 2023 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's leading volunteer eye health and safety nonprofit organization, has declared August as Children's Eye Health and Safety Month in an effort to educate parents and caregivers on ways to keep children's eyes healthy. As many kids are headed back to school in the month of August, Prevent Blindness offers free resources including fact sheets and social media graphics in English and Spanish, toolkits, and webpages on a variety of topics, including myopia (nearsightedness), amblyopia (lazy eye), strabismus (crossed eyes), eye safety in relation to digital screen time, importance of vision screenings, financial assistance programs, and much more.

Key Points: 
  • Prevent Blindness Offers New Episode of its Focus on Eye Health Expert Series, Collaborative Episode of the BlackDoctor.org "Seeing Eye to Eye" Series, Resources for Families and Children for the Upcoming Solar Eclipses, and More.
  • CHICAGO, July 31, 2023 /PRNewswire-PRWeb/ -- Prevent Blindness , the nation's leading volunteer eye health and safety nonprofit organization, has declared August as Children's Eye Health and Safety Month in an effort to educate parents and caregivers on ways to keep children's eyes healthy.
  • Additionally, Prevent Blindness is debuting a new episode in the online Focus on Eye Health Expert Series, " Children's Vision and Eye Health ."
  • And, as part of the Focus on Eye Health Expert series, Michael F. Chiang, MD , Director of the National Eye Institute (NEI), recently spoke with Jeff Todd

Prevent Blindness Issues Call for Nominations for the 2023 Jenny Pomeroy Award for Excellence in Vision and Public Health, and Rising Visionary Award

Retrieved on: 
Wednesday, January 4, 2023
Eye, School, University, Massachusetts Eye and Ear, Public health, Head, Research, UAB, Ohio Department of Health, Master of Science, FACS, OD, United States Department of Veterans Affairs, Research to Prevent Blindness, New England College, University of Illinois Urbana-Champaign, Veterans' affairs, Visual Science, Illinois Eye and Ear Infirmary, DPA, University college, Visual impairment, MBA, Doctor of Philosophy, Professor, Policy, Ear, Johns Hopkins University, Severe cognitive impairment, Essay, New England College of Optometry, ROP, University of Alabama, Bascom Palmer Eye Institute, UIC, New England, Pharmaceutical industry, Management, Optometry, Ophthalmology, MD, Child, MPH

CHICAGO, Jan. 4, 2023 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's oldest volunteer eye health and safety organization, is issuing the call for nominations for the "2023 Jenny Pomeroy Award for Excellence in Vision and Public Health," and the fourth annual "Rising Visionary Award." Both awards will be formally presented at the 12th Annual Prevent Blindness Focus on Eye Health National Summit, on July 12-13, 2023.

Key Points: 
  • Both awards will be formally presented at the 12th Annual Prevent Blindness Focus on Eye Health National Summit, on July 12-13, 2023.
  • The highest honor that Prevent Blindness bestows, the award is a tribute to Jenny Pomeroy, who was the CEO of Prevent Blindness Georgia from 1996 until 2013, and an accomplished leader in advancing public health and policy for vision and eye health issues.
  • The recipient of the 2022 Jenny Pomeroy Award for Excellence in Vision and Public Health was VOSH/International, a volunteer-based organization.
  • For more information on the Prevent Blindness Jenny Pomeroy Award for Excellence in Vision and Public Health, please visit https://preventblindness.org/jenny-pomeroy-award-for-excellence-in-visio... .

Dr. Robert Folberg Joins EyeCare Partners Innovation Center to Lead Clinical Education, Physician Recruitment Efforts

Retrieved on: 
Wednesday, November 2, 2022
Research, Technology, Human Resources, Other Technology, Professional Services, Continuing, Health, Optical, Science, Education, Ophthalmic pathology, National Eye Institute, Illinois Eye and Ear Infirmary, University of Illinois at Chicago College of Dentistry, Research, Ophthalmology, Physician, Innovation Center station, Optometry, Head, ECP, House Ear Institute, Oakland University, Partner, University, Patient, Education, Pathology, Medicine, Hospital

EyeCare Partners (ECP), the nations leading provider of clinically integrated eye care, has named Robert Folberg, M.D., as Vice President of Education as part of the companys newly launched Innovation Center.

Key Points: 
  • EyeCare Partners (ECP), the nations leading provider of clinically integrated eye care, has named Robert Folberg, M.D., as Vice President of Education as part of the companys newly launched Innovation Center.
  • Many ophthalmologists want to serve patients in a clinical setting, but also want a career that includes clinical research, said Dr. Folberg.
  • EyeCare Partners offers physicians the flexibility to do both as part of a world-class team of optometrists and ophthalmologists.
  • With the launch of the new EyeCare Partners Innovation Center, ECP is focused on promoting an organization-wide culture of collaborative innovation.

Prevent Blindness Declares Second Annual Inflammatory Eye Disease Awareness Week as Sept. 26 - Oct. 2

Retrieved on: 
Tuesday, September 20, 2022
YouTube, American Academy, Safety, Autoimmune disease, Department, Awareness, Eye disease, Twitter, Risk, Visual Science, Disease, Virus, Conjunctivitis, LinkedIn, Inflammation, Social media, Logansport Memorial Hospital, Severe cognitive impairment, Infection, Patient, CEO, Instagram, Irritation, List of minor secular observances, Bacteria, Illinois College, Diagnosis, Rheumatoid arthritis, Associate, Research, Keratitis, Illinois Eye and Ear Infirmary, American Academy of Ophthalmology, University, Immune system, Emergency medicine, Visual impairment, Graves' ophthalmopathy, IED, Pharmaceutical industry, Mallinckrodt, Uveitis, Facebook, Ophthalmology

CHICAGO, Sept. 20, 2022 /PRNewswire-PRWeb/ -- Prevent Blindness, the nation's leading eye health and safety nonprofit organization, has declared Sept. 26 – Oct. 2, 2022, as the second annual Inflammatory Eye Disease (IED) Awareness Week. IED includes a range of conditions associated with eye inflammation. Inflammation is the body's response to injury, infection, or irritation. Most cases of eye inflammation can be successfully treated. However, in rare cases there can be a serious disease present, which is a threat to the eyesight.

Key Points: 
  • CHICAGO, Sept. 20, 2022 /PRNewswire-PRWeb/ -- Prevent Blindness , the nation's leading eye health and safety nonprofit organization, has declared Sept. 26 Oct. 2, 2022, as the second annual Inflammatory Eye Disease (IED) Awareness Week.
  • Prevent Blindness offers a dedicated webpage providing detailed information on IED, downloadable fact sheets in English and Spanish, and resources for eye care.
  • "Inflammatory Eye Disease is a term that encompasses a wide variety of diseases and symptoms," said Jeff Todd, president and CEO of Prevent Blindness.
  • Founded in 1908, Prevent Blindness is the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight.

SIFI RECEIVES FAVORABLE FEEDBACK FROM THE US FDA ON AKANTIOR® FOR THE TREATMENT OF ACANTHAMOEBA KERATITIS

Retrieved on: 
Monday, May 16, 2022
Company, Disease, Polyhexanide, Acanthamoeba keratitis, Eye, Incidence, NCE, Cyst, Patient, Quality of life, Severe cognitive impairment, SIFI, Research, Patent, FDA, Trophozoite, Massachusetts Eye and Ear, Transplant, University, Orphan, NDA, American Journal, Illinois Eye and Ear Infirmary, AK, The Company, Ophthalmology, MD, Fungal keratitis, CEO, Pharmaceutical industry, Acanthamoeba, New chemical entity

ABOUT AKANTIOR: AKANTIOR (polihexanide) stands to become the first approved drug for the treatment of acanthamoeba keratitis in the world.

Key Points: 
  • ABOUT AKANTIOR: AKANTIOR (polihexanide) stands to become the first approved drug for the treatment of acanthamoeba keratitis in the world.
  • Polihexanide is also being developed by SIFI for the treatment of fungal keratitis for which indication it also has FDA Orphan Drug Designation.
  • ABOUT Acanthamoeba Keratitis (AK): AK is a rare, acute, severe parasitic corneal infection caused by Acanthamoeba, a free-living amoeba.
  • ABOUT SIFI: SIFI is a leading international ophthalmic company, headquartered in Italy, focusing on eye care since 1935.

SIFI RECEIVES FAVORABLE FEEDBACK FROM THE US FDA ON AKANTIOR® FOR THE TREATMENT OF ACANTHAMOEBA KERATITIS

Retrieved on: 
Monday, May 16, 2022
Company, Disease, Polyhexanide, Acanthamoeba keratitis, Eye, Incidence, NCE, Cyst, Patient, Quality of life, Severe cognitive impairment, SIFI, Research, Patent, FDA, Trophozoite, Massachusetts Eye and Ear, Transplant, University, Orphan, NDA, American Journal, Illinois Eye and Ear Infirmary, AK, The Company, Ophthalmology, MD, Fungal keratitis, CEO, Pharmaceutical industry, Acanthamoeba, New chemical entity

ABOUT AKANTIOR: AKANTIOR (polihexanide) stands to become the first approved drug for the treatment of acanthamoeba keratitis in the world.

Key Points: 
  • ABOUT AKANTIOR: AKANTIOR (polihexanide) stands to become the first approved drug for the treatment of acanthamoeba keratitis in the world.
  • Polihexanide is also being developed by SIFI for the treatment of fungal keratitis for which indication it also has FDA Orphan Drug Designation.
  • ABOUT Acanthamoeba Keratitis (AK): AK is a rare, acute, severe parasitic corneal infection caused by Acanthamoeba, a free-living amoeba.
  • ABOUT SIFI: SIFI is a leading international ophthalmic company, headquartered in Italy, focusing on eye care since 1935.

Call for Nominations Issued for 2022 Prevent Blindness Jenny Pomeroy Award for Excellence in Vision and Public Health, and Rising Visionary Award

Retrieved on: 
Wednesday, January 5, 2022
University of Alabama, Severe cognitive impairment, Policy, Primary health care, Nursing, University, School, Optometry, Doctor of Philosophy, Illinois Eye and Ear Infirmary, Johns Hopkins University, Head, Research, Organization, Research to Prevent Blindness, UIC, UAB, OD, ROP, Twitter, FACS, Ohio State University, New England College of Optometry, CEO, Essay, Public health, MBA, Department, Ohio Department of Health, DPA, LinkedIn, Instagram, Eye, Visual Science, Master of Science, New England College, YouTube, Visual impairment, University of Illinois Urbana-Champaign, New England, Professor, Pharmaceutical industry, Management, MD, Facebook, Ophthalmology

CHICAGO, Jan. 5, 2022 /PRNewswire-PRWeb/ -- Prevent Blindness , the nation's oldest volunteer eye health and safety organization, is issuing the call for nominations for the " 2022 Jenny Pomeroy Award for Excellence in Vision and Public Health ," and the third annual " Rising Visionary Award ."

Key Points: 
  • CHICAGO, Jan. 5, 2022 /PRNewswire-PRWeb/ -- Prevent Blindness , the nation's oldest volunteer eye health and safety organization, is issuing the call for nominations for the " 2022 Jenny Pomeroy Award for Excellence in Vision and Public Health ," and the third annual " Rising Visionary Award ."
  • The recipient of the 2021 Jenny Pomeroy Award for Excellence in Vision and Public Health was R.V.
  • The 2021 Rising Visionary Award recipient was Shervonne Poleon, Vision Science Graduate Program student, University of Alabama at Birmingham (UAB).
  • For more information on the Prevent Blindness Jenny Pomeroy Award for Excellence in Vision and Public Health, please visit https://preventblindness.org/jenny-pomeroy-award-for-excellence-in-visio... .

Prevent Blindness Declares First-ever Inflammatory Eye Disease Awareness Week as Sept. 27 - Oct. 3

Retrieved on: 
Tuesday, September 21, 2021
Social media, Irritation, Trauma, Severe cognitive impairment, Illinois Eye and Ear Infirmary, Diagnosis, Degenerative disease, Graves' ophthalmopathy, Interview, Uveitis, Infection, Inflammation, Conjunctiva, Logansport Memorial Hospital, Disorder, Patient, Parasitism, Keratitis, Bacteria, Virus, Eyelid, Injury, Immune system, Visual impairment, Illinois College, CEO, University, Swelling, Graves' disease, Awareness, Associate, Disease, Fungus, IED, Iris, Uvea, Eye, Pupil, Tissue, Research, Visual Science, Autoimmune disease, Allergy, Hyperthyroidism, Emergency medicine, Mucous membrane, Corneal ulcer, Cornea, Department, Pharmaceutical industry, Cosmetics, Vaccine

CHICAGO, Sept. 21, 2021 /PRNewswire-PRWeb/ -- In an effort to educate the public on the various forms of Inflammatory Eye Disease (IED), Prevent Blindness , the nation's oldest volunteer eye health organization, has declared Sept. 27 Oct. 3, 2021, as the first-ever Inflammatory Eye Disease Awareness Week.

Key Points: 
  • CHICAGO, Sept. 21, 2021 /PRNewswire-PRWeb/ -- In an effort to educate the public on the various forms of Inflammatory Eye Disease (IED), Prevent Blindness , the nation's oldest volunteer eye health organization, has declared Sept. 27 Oct. 3, 2021, as the first-ever Inflammatory Eye Disease Awareness Week.
  • Additionally, shareable social media graphics will be posted on the Prevent Blindness social media channels throughout the week.
  • "As with most eye diseases and conditions, access to quality eyecare and treatment can help prevent vision loss and even blindness from Inflammatory Eye Disease," said Jeff Todd, president and CEO of Prevent Blindness.
  • Founded in 1908, Prevent Blindness is the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight.

Eighteen Eye Consultants of Atlanta physicians receive Top Doctors honors in Atlanta

Retrieved on: 
Thursday, July 1, 2021
Health care, Health, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, Ophthalmology, Consultant

Atlanta, GA, July 01, 2021 (GLOBE NEWSWIRE) -- Eighteen physicians from Eye Consultants of Atlanta the largest ophthalmology practice in Georgia rank among Castle Connollys Top Doctors.

Key Points: 
  • Atlanta, GA, July 01, 2021 (GLOBE NEWSWIRE) -- Eighteen physicians from Eye Consultants of Atlanta the largest ophthalmology practice in Georgia rank among Castle Connollys Top Doctors.
  • He completed his residency at the University of Rochester and his fellowship training at Eye Consultants of Atlanta.
  • He completed his residency training at the Illinois Eye and Ear Infirmary and his fellowship training at Eye Consultants of Atlanta.
  • Eye Consultants of Atlanta Since 1973, Eye Consultants of Atlanta has made improving your vision, our vision.

Santen Announces Global Research Initiative with Massachusetts Eye and Ear and Ulster University Researchers to Study and Develop New Treatments for Glaucoma

Retrieved on: 
Monday, April 12, 2021
Health care, Healthcare in the United States, Ophthalmology, Harvard Medical School, Massachusetts Eye and Ear, Glaucoma, Ocular hypertension, Illinois Eye and Ear Infirmary

The nerve can become damaged from conditions such as ocular hypertension and glaucoma, thereby leading to vision impairment or loss.

Key Points: 
  • The nerve can become damaged from conditions such as ocular hypertension and glaucoma, thereby leading to vision impairment or loss.
  • I\'m also delighted to be working on this project with Mass Eye and Ear as we are long standing collaborators and their research compliments ours perfectly.
  • "\nAs a global specialized company dedicated to ophthalmology, Santen carries out research, development, marketing, and sales of pharmaceuticals, over-the-counter products, and medical devices.
  • A member of Mass General Brigham , Mass Eye and Ear specializes in ophthalmology (eye care) and otolaryngologyhead and neck surgery (ear, nose and throat care).